Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Preliminary investigation of peripheral extracellular vesicles' microRNAs in bipolar disorder.

Fries GR, Lima CNC, Valvassori SS, Zunta-Soares G, Soares JC, Quevedo J.

J Affect Disord. 2019 May 14;255:10-14. doi: 10.1016/j.jad.2019.05.020. [Epub ahead of print]

PMID:
31125858
2.

Moving pharmacoepigenetics tools for depression toward clinical use.

Hack LM, Fries GR, Eyre HA, Bousman CA, Singh AB, Quevedo J, John VP, Baune BT, Dunlop BW.

J Affect Disord. 2019 Apr 15;249:336-346. doi: 10.1016/j.jad.2019.02.009. Epub 2019 Feb 6. Review.

PMID:
30802699
3.

MicroRNAs in Major Depressive Disorder.

Fries GR, Zhang W, Benevenuto D, Quevedo J.

Adv Exp Med Biol. 2019;1118:175-190. doi: 10.1007/978-3-030-05542-4_9.

PMID:
30747423
4.

Revisiting inflammation in bipolar disorder.

Fries GR, Walss-Bass C, Bauer ME, Teixeira AL.

Pharmacol Biochem Behav. 2019 Feb;177:12-19. doi: 10.1016/j.pbb.2018.12.006. Epub 2018 Dec 24. Review.

PMID:
30586559
5.

TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation.

Scaini G, Barichello T, Fries GR, Kennon EA, Andrews T, Nix BR, Zunta-Soares G, Valvassori SS, Soares JC, Quevedo J.

Neuropsychopharmacology. 2019 Jun;44(7):1291-1299. doi: 10.1038/s41386-018-0293-4. Epub 2018 Dec 11.

PMID:
30575805
6.

Biomarkers for bipolar disorder: current status and challenges ahead.

Teixeira AL, Colpo GD, Fries GR, Bauer IE, Selvaraj S.

Expert Rev Neurother. 2019 Jan;19(1):67-81. doi: 10.1080/14737175.2019.1550361. Epub 2018 Nov 28.

PMID:
30451546
7.

The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders.

Mansur RB, Fries GR, Trevizol AP, Subramaniapillai M, Lovshin J, Lin K, Vinberg M, Ho RC, Brietzke E, McIntyre RS.

Eur Neuropsychopharmacol. 2019 Jan;29(1):137-146. doi: 10.1016/j.euroneuro.2018.10.007. Epub 2018 Nov 6.

PMID:
30409537
8.

Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes.

Mansur RB, Fries GR, Subramaniapillai M, Frangou S, De Felice FG, Rasgon N, McEwen B, Brietzke E, McIntyre RS.

J Psychiatr Res. 2018 Dec;107:128-135. doi: 10.1016/j.jpsychires.2018.10.020. Epub 2018 Oct 27.

PMID:
30391805
9.

Are lithium effects dependent on genetic/epigenetic architecture?

Walss-Bass C, Fries GR.

Neuropsychopharmacology. 2019 Jan;44(1):228. doi: 10.1038/s41386-018-0194-6. No abstract available.

PMID:
30194423
10.

The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.

Brietzke E, Trevizol AP, Fries GR, Subramaniapillai M, Kapczinski F, McIntyre RS, Mansur RB.

J Psychiatr Res. 2018 Jul;102:186-191. doi: 10.1016/j.jpsychires.2018.04.012. Epub 2018 Apr 13.

PMID:
29680575
11.

Exosomal MicroRNAs as Potential Biomarkers in Neuropsychiatric Disorders.

Fries GR, Quevedo J.

Methods Mol Biol. 2018;1733:79-85. doi: 10.1007/978-1-4939-7601-0_6. Review.

PMID:
29435924
12.

Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder.

Fries GR, Bauer IE, Scaini G, Wu MJ, Kazimi IF, Valvassori SS, Zunta-Soares G, Walss-Bass C, Soares JC, Quevedo J.

Transl Psychiatry. 2017 Dec 11;7(12):1283. doi: 10.1038/s41398-017-0048-8.

13.

The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Fries GR, Gassen NC, Rein T.

Int J Mol Sci. 2017 Dec 5;18(12). pii: E2614. doi: 10.3390/ijms18122614. Review.

14.

The miRNome of bipolar disorder.

Fries GR, Carvalho AF, Quevedo J.

J Affect Disord. 2018 Jun;233:110-116. doi: 10.1016/j.jad.2017.09.025. Epub 2017 Sep 23. Review.

PMID:
28969861
15.

Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.

Fries GR, Colpo GD, Monroy-Jaramillo N, Zhao J, Zhao Z, Arnold JG, Bowden CL, Walss-Bass C.

Eur Neuropsychopharmacol. 2017 Nov;27(11):1110-1119. doi: 10.1016/j.euroneuro.2017.09.003. Epub 2017 Sep 20.

16.

Biomarkers in first-degree relatives of patients with bipolar disorder: what can they tell us?

Fries GR, Quevedo J.

Braz J Psychiatry. 2017 Jul-Sep;39(3):277-278. doi: 10.1590/1516-4446-2017-2302. No abstract available.

17.

Analyzing leukocyte telomere length in bipolar disorder: Authors' reply.

Barbé-Tuana FM, Parisi MM, Panizzutti BS, Fries GR, Grun LK, Guma FT, Kapczinski F, Berk M, Gama CS, Rosa AR.

Braz J Psychiatry. 2017 Jul-Sep;39(3):275-276. doi: 10.1590/1516-4446-2017-2350. No abstract available.

18.

Genome-wide expression in veterans with schizophrenia further validates the immune hypothesis for schizophrenia.

Fries GR, Dimitrov DH, Lee S, Braida N, Yantis J, Honaker C, Cuellar J, Walss-Bass C.

Schizophr Res. 2018 Feb;192:255-261. doi: 10.1016/j.schres.2017.06.016. Epub 2017 Jun 20.

PMID:
28641886
19.

Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia.

Deng H, Kahlon RS, Mohite S, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Fries GR, Walss-Bass C, Soares JC, Okusaga OO.

Psychiatr Q. 2018 Mar;89(1):53-60. doi: 10.1007/s11126-017-9514-y.

PMID:
28435992
20.

Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.

Mohite S, Yang F, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Sharma AN, Fries GR, Walss-Bass C, Soares JC, Okusaga OO.

PLoS One. 2017 Mar 23;12(3):e0174073. doi: 10.1371/journal.pone.0174073. eCollection 2017.

Supplemental Content

Loading ...
Support Center